Reversal of p-glycoprotein-mediated multidrug resistance by CJX1, an amlodipine derivative, in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells

Life Sciences

Volumn 77, Issue 18, 2005, Pages 2221-2232

  Ji, Bian Sheng ^a   He, Ling ^a   Liu, Guo Qing ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

CJX1; Doxorubicin; Multidrug resistance; P glycoprotein

Indexed keywords

AMLODIPINE; CJX 1; DOXORUBICIN; GLYCOPROTEIN P; RHODAMINE 123; UNCLASSIFIED DRUG; VERAPAMIL;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL STRAIN K 562; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG POTENCY; DRUG POTENTIATION; DRUG UPTAKE; HUMAN; HUMAN CELL; INCUBATION TIME; MULTIDRUG RESISTANCE; MYELOID LEUKEMIA;

AMLODIPINE; ANALYSIS OF VARIANCE; APOPTOSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG THERAPY; FLOW CYTOMETRY; FLUORESCENCE; HUMANS; K562 CELLS; NEOPLASMS; P-GLYCOPROTEIN; RHODAMINE 123; TETRAZOLIUM SALTS; THIAZOLES; TIME FACTORS; VERAPAMIL;

EID: 23844445265     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2004.12.050     Document Type: Article

References (26)

1. R. Belhoussine, H. Morjani, S. Sharonov, D. Ploton, and M. Manfait Characterization of intracellular pH gradients in human multidrug-resistant tumor cells by means of scanning microspectrofluorometry and dual-emission-ratio probes International Journal of Cancer 81 1 1999 81 89
2. C. Bezombes, N. Maestre, G. Laurent, T. Levade, A. Bettaieb, and J.P. Jaffrezou Restoration of TNF-alpha-induced ceramide generation and apoptosis in resistant human leukemia KG1a cells by the P-glycoprotein blocker PSC833 FASEB Journal 12 1 1998 101 109
3. M. Briffod, F. Spyratos, K. Hacene, M. Tubiana-Hulin, C. Pallud, F. Gilles, and J. Rouesse Evaluation of breast carcinoma chemosensitivity by flow cytometric DNA analysis and computer assisted image analysis Cytometry 13 3 1992 250 258
4. G. Chen, J.P. Jaffrezou, W.H. Fleming, G.E. Duran, and B.I Sikic Prevalence of multidrug resistance related to activation of the mdr1 gene in human sarcoma mutants derived by single-step doxorubicin selection Cancer Research 54 18 1994 4980 4987
5. T.D. Chung, F.H. Drake, K.B. Tan, S.R. Per, S.T. Crooke, and C.K. Mirabelli Characterization and immunological identification of cDNA clones encoding two human DNA topoisomerase II isozymes Proceedings of the National Academy of Sciences of the United States of America 86 23 1989 9431 9435
6. F.H. Drake, G.A. Hofmann, H.F. Bartus, M.R. Mattern, S.T. Crooke, and C.K. Mirabelli Biochemical and pharmacological properties of p170 and p180 forms of topoisomerase II Biochemistry 28 20 1989 8154 8160
7. J. Gong, F. Traganos, and Z. Darzynkiewicz A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry Analytical Biochemistry 218 2 1994 314 319
8. M.M. Gottesman, and I. Pastan Biochemistry of multidrug resistance mediated by the multidrug transporter Annual Review of Biochemistry 62 1993 385 427
9. R.A. Gottlieb, J. Nordberg, E. Skowronski, and B.M. Babior Apoptosis induced in Jurkat cells by several agents is preceded by intracellular acidification Proceedings of the National Academy of Sciences of the United States of America 93 2 1996 654 658
10. L.J. Green, P. Marder, and C.A. Slapak Modulation by LY335979 of P-glycoprotein function in multidrug-resistant cell lines and human natural killer cells Biochemical Pharmacology 61 11 2001 1393 1399
11. M.M. Heck, W.N. Hittelman, and WC. Earnshaw Differential expression of DNA topoisomerases I and II during the eukaryotic cell cycle Proceedings of the National Academy of Sciences of the United States of America 85 4 1988 1086 1090
12. 3H]vinblastine transport by isolated vesicles Biochimica et Biophysica Acta 1061 1 1991 106 110
13. T. Ikegawa, F. Ushigome, N. Koyabu, S. Morimoto, Y. Shoyama, M. Naito, T. Tsuruo, H. Ohtani, and Y. Sawada Inhibition of P-glycoprotein by orange juice components, polymethoxyflavones in adriamycin-resistant human myelogenous leukemia (K562/ADM) cells Cancer Letters 160 1 2000 21 28 (Nov. 10)
14. T. Ikegawa, H. Ohtani, N. Koyabu, M. Juichi, Y. Iwase, C. Ito, H. Furukawa, M. Naito, T. Tsuruo, and Y. Sawada Inhibition of P-glycoprotein by flavonoid derivatives in adriamycin-resistant human myelogenous leukemia (K562/ADM) cells Cancer Letters 177 1 2002 89 93
15. R.W. Johnstone, E. Cretney, and M.J. Smyth P-glycoprotein protects leukemia cells against caspase-dependent, but not caspase-independent, cell death Blood 93 3 1999 1075 1085
16. M. Katoh, M. Nakajima, H. Yamazaki, and T. Yokoi Inhibitory potencies of 1,4-dihydropyridine calcium antagonists to P-glycoprotein-mediated transport: comparison with the effects on CYP3A4 Pharmaceutical Research 17 10 2000 1189 1197
17. Hansen Morten Bagge, Svend Erik Nielsen, and Kurt Berg Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill Journal of Immunological Methods 119 1998 203 210
18. H. Nakano, T. Yamazaki, S. Miyatake, N. Nozaki, A. Kikuchi, and T. Saito Specific interaction of topoisomerase II beta and the CD3 epsilon chain of the T cell receptor complex Journal of Biological Chemistry 271 11 1996 6483 6489
19. D. Nielsen, C. Maare, and T. Skovsgaard Cellular resistance to anthracyclines General Pharmacology 27 2 1996 251 255
20. Y. Ohbayashi, T. Tsutamoto, T. Sakaguchi, T. Tanaka, T. Kanamori, H. Yokohama, G. Sichiri, D. Hukai, T. Okabayashi, T. Ozawa, C. Ishii, T. Tsutsui, K. Ohno, M. Ohnishi, and A. Wada Effect of an angiotensin II type 1 receptor blocker, valsartan, on neurohumoral factors in patients with hypertension: comparison with a long-acting calcium channel antagonist, amlodipine Journal of Cardiovascular Pharmacology 42 Suppl. 1 2003 S71 S74
21. R.L. Page, C.S. Hughes, S. Huyan, J. Sagris, and M. Trogdon Modulation of P-glycoprotein-mediated doxorubicin resistance in canine cell lines Anticancer Research 20 5B 2000 3533 3538
22. C.M. Sorenson, and A. Eastman Mechanism of cis- diamminedichloroplatinum(II)-induced cytotoxicity: role of G2 arrest and DNA double-strand breaks Cancer Research 48 16 1988 4484 4488
23. C.A. Tatu, V. Paunescu, D.I. Stanescu, and F. Schneider P-glycoprotein mediated multidrug resistance assessment by flow-cytometry in malignant hemopathies Anticancer Research 17 4A 1997 2583 2586
24. P.R. Twentyman Modification of cytotoxic drug resistance by non-immuno-suppressive cyclosporins British Journal of Cancer 57 3 1988 254 258
25. J.H. Weisburg, M. Curcio, P.C. Caron, G. Raghu, E.B. Mechetner, P.D. Roepe, and D.A. Scheinberg The multidrug resistance phenotype confers immunological resistance Journal of Experimental Medicine 183 6 1996 2699 2704
26. Z. Xia, M. Dickens, J. Raingeaud, R.J. Davis, and M.E. Greenberg Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis Science 270 5240 1995 1326 1331